Literature DB >> 2167442

A cellular factor binds to the herpes simplex virus type 1 transactivator Vmw65 and is required for Vmw65-dependent protein-DNA complex assembly with Oct-1.

P Xiao1, J P Capone.   

Abstract

The herpes simplex virus transactivator Vmw65 assembles into a multicomponent protein-DNA complex along with the octamer binding protein Oct-1. Using affinity chromatography on columns conjugated with purified Vmw65 fusion protein expressed in Escherichia coli, we demonstrate that a cellular factor, distinct from Oct-1, binds to Vmw65 in the absence of target DNA and is necessary for Vmw65-mediated complex assembly with Oct-1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167442      PMCID: PMC361125          DOI: 10.1128/mcb.10.9.4974-4977.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  27 in total

Review 1.  Herpes simplex virus Vmw65-octamer binding protein interaction: a paradigm for combinatorial control of transcription.

Authors:  C R Goding; P O'Hare
Journal:  Virology       Date:  1989-12       Impact factor: 3.616

2.  Nucleotide sequence and predicted amino acid sequence of a protein encoded in a small herpes simplex virus DNA fragment capable of trans-inducing alpha genes.

Authors:  P E Pellett; J L McKnight; F J Jenkins; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

3.  DNA sequence of the herpes simplex virus type 1 gene whose product is responsible for transcriptional activation of immediate early promoters.

Authors:  M A Dalrymple; D J McGeoch; A J Davison; C M Preston
Journal:  Nucleic Acids Res       Date:  1985-11-11       Impact factor: 16.971

4.  Analysis of DNA sequences which regulate the transcription of herpes simplex virus immediate early gene 3: DNA sequences required for enhancer-like activity and response to trans-activation by a virion polypeptide.

Authors:  D J Bzik; C M Preston
Journal:  Nucleic Acids Res       Date:  1986-01-24       Impact factor: 16.971

5.  Host cell proteins bind to the cis-acting site required for virion-mediated induction of herpes simplex virus 1 alpha genes.

Authors:  T M Kristie; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

6.  In vitro transcription: whole-cell extract.

Authors:  J L Manley; A Fire; M Samuels; P A Sharp
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  Separation of sequences defining basal expression from those conferring alpha gene recognition within the regulatory domains of herpes simplex virus 1 alpha genes.

Authors:  T M Kristie; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

9.  Characterization of the herpes simplex virion-associated factor responsible for the induction of alpha genes.

Authors:  W Batterson; B Roizman
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

10.  Regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with alpha gene promoters.

Authors:  L E Post; S Mackem; B Roizman
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

View more
  57 in total

1.  Global analysis of herpes simplex virus type 1 transcription using an oligonucleotide-based DNA microarray.

Authors:  S W Stingley; J J Ramirez; S A Aguilar; K Simmen; R M Sandri-Goldin; P Ghazal; E K Wagner
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Autocatalytic proteolysis of the transcription factor-coactivator C1 (HCF): a potential role for proteolytic regulation of coactivator function.

Authors:  J L Vogel; T M Kristie
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

3.  Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.

Authors:  T Ragoczy; G Miller
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  The VP16 paradox: herpes simplex virus VP16 contains a long-range activation domain but within the natural multiprotein complex activates only from promoter-proximal positions.

Authors:  M Hagmann; O Georgiev; W Schaffner
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  Truncation of the C-terminal acidic transcriptional activation domain of herpes simplex virus VP16 produces a phenotype similar to that of the in1814 linker insertion mutation.

Authors:  J R Smiley; J Duncan
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

6.  Luman, a new member of the CREB/ATF family, binds to herpes simplex virus VP16-associated host cellular factor.

Authors:  R Lu; P Yang; P O'Hare; V Misra
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

7.  Differences in determinants required for complex formation and transactivation in related VP16 proteins.

Authors:  M Grapes; P O'Hare
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  Immediate-early expression of the herpes simplex virus type 1 ICP27 transcript is not critical for efficient replication in vitro or in vivo.

Authors:  Aixu Sun; G V Devi-Rao; M K Rice; L W Gary; D C Bloom; R M Sandri-Goldin; P Ghazal; E K Wagner
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  The extreme carboxyl terminus of the equine herpesvirus 1 homolog of herpes simplex virus VP16 is essential for immediate-early gene activation.

Authors:  G D Elliott
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Protein and DNA elements involved in transactivation of the promoter of the bovine herpesvirus (BHV) 1 IE-1 transcription unit by the BHV alpha gene trans-inducing factor.

Authors:  V Misra; A C Bratanich; D Carpenter; P O'Hare
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.